Health

    Women's Health

Post-Doctoral Fellowships

Ireland

Reducing maternal mortality by diagnosing undetected bleeding disorders

Irish hematologist Michelle Lavin has been studying gynecological bleeding and developing a technique that allows obstetricians to screen patients with an undiagnosed low von Willebrand factor (VWF), which is a protein that helps control bleeding. Identifying which women have a low VWF before they give birth would allow delivery room medical staff to be aware of bleeding risk and thus plan accordingly. This could help save lives and reduce the occurrence of postpartum hemorrhage (PPH), which is a major maternal health problem around the world.

 

The results from Dr. Lavin’s PPH-prevention study will be used to develop “bleeding scores” that can help predict which women are at risk of PPH. This is an important step towards improving maternal outcomes. If these scores prove useful, this tool will be implemented for all pregnant women in the future – ideally, in the next two to three years.

Michelle
LAVIN

Institution

Irish Centre for Vascular Biology

Country

Ireland

Nationality

Irish

ORCID Open Researcher and Contributor ID, a unique and persistent identifier to researchers